Jessica Williams Selected Research

Hemorrhage

1/2020

Therapeutic resolution of focal, predominantly anastomotic Crohn's disease strictures using removable stents: outcomes from a single-center case series in the United Kingdom.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jessica Williams Research Topics

Disease

8	Neoplasms (Cancer) 01/2023 - 10/2009
4	Inflammation (Inflammations) 01/2023 - 12/2015
4	Malaria 03/2022 - 07/2015
2	Opioid-Related Disorders (Opiate Addiction) 01/2019 - 01/2015
1	Pain (Aches) 04/2024
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2023
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2023
1	Lymphoma (Lymphomas) 09/2023
1	Bacterial Infections (Bacterial Infection) 03/2023
1	Lung Diseases (Lung Disease) 03/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Alzheimer Disease (Alzheimer's Disease) 05/2022
1	Neuroinflammatory Diseases 05/2022
1	Carcinogenesis 01/2022
1	Mucositis 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Arthritis (Polyarthritis) 01/2021
1	Experimental Arthritis 01/2021
1	Atherosclerosis 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Ischemia 06/2020
1	Hemorrhage 01/2020
1	Pathologic Constriction (Stenosis) 01/2020
1	Crohn Disease (Crohn's Disease) 01/2020
1	Acute Liver Failure (Fulminant Hepatic Failure) 02/2018
1	Hematologic Neoplasms (Hematological Malignancy) 10/2017
1	Starvation 01/2017
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Hyperglycemia 01/2017
1	Acidosis 01/2017
1	Gallstones (Gallstone) 01/2017
1	Pituitary ACTH Hypersecretion 01/2017
1	Brain Injuries (Brain Injury) 01/2017
1	Necrosis 05/2014
1	Traumatic Brain Injuries (Traumatic Brain Injury) 07/2013
1	Brain Ischemia (Cerebral Ischemia) 07/2013

Drug/Important Bio-Agent (IBA)

3	InsecticidesIBA 03/2022 - 11/2019
2	Pyrethrins (Pyrethroids)FDA Link 03/2022 - 02/2022
2	Oxygen (Dioxygen)IBA 06/2020 - 01/2017
2	Valosin Containing ProteinIBA 01/2019 - 11/2016
2	PoisonsIBA 01/2019 - 01/2019
2	AminopeptidasesIBA 01/2019 - 10/2017
1	NeuropeptidesIBA 04/2024
1	Opioid Receptors (Opioid Receptor)IBA 04/2024
1	EnkephalinsIBA 04/2024
1	enkephalin degrading enzymeIBA 04/2024
1	Opioid Analgesics (Opioids)IBA 04/2024
1	Methionine EnkephalinIBA 04/2024
1	ibrutinibIBA 09/2023
1	milatuzumabIBA 09/2023
1	Chimeric Antigen ReceptorsIBA 09/2023
1	Monoclonal AntibodiesIBA 09/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2023
1	bemcentinibIBA 01/2023
1	Docetaxel (Taxotere)FDA Link 01/2023
1	Blood Proteins (Serum Proteins)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023
1	ProteomeIBA 01/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023
1	DipeptidesIBA 05/2022
1	Voltage-Gated Sodium ChannelsIBA 03/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Benzene (Benzole)IBA 01/2022
1	OligosaccharidesIBA 01/2022
1	2'-fucosyllactoseIBA 01/2022
1	phenethyl isothiocyanate (PEITC)IBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	CarcinogensIBA 01/2022
1	Environmental CarcinogensIBA 01/2022
1	CytokinesIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	MetalsIBA 01/2020
1	tyrosyl-DNA phosphodiesteraseIBA 01/2019
1	tosedostatIBA 01/2019
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2019
1	Acetaminophen (Paracetamol)FDA LinkGeneric 02/2018
1	PuromycinIBA 10/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	pasireotideIBA 01/2017
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2017
1	Glutamic Acid (Glutamate)FDA Link 01/2017
1	1- (4- chlorophenyl)- 3- (3- (4- chlorophenyl)- 5,5- dimethyl- 1- (3- (5- nitrofuran- 2- yl)allyldienehydrazinocarbonylmethyl)- 2- oxoimidazolidin- 4- yl)- 1- hydroxyureaIBA 11/2016
1	Immunologic Factors (Immunomodulators)IBA 12/2015
1	Coloring Agents (Dyes)IBA 07/2015
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2015
1	BilirubinIBA 05/2014
1	Bile Acids and Salts (Bile Acids)IBA 05/2014
1	Neuroprotective AgentsIBA 07/2013

Therapy/Procedure

4	Therapeutics 01/2022 - 11/2016
1	Phage Therapy 03/2023
1	Drug Therapy (Chemotherapy) 01/2022
1	Stents 01/2020